整个欧洲的儿科初级保健:对42个国家的调查
Nora Karara1,2,3, Antonio Corsello1,4,5, Stefano Del Torso1,6
1European Academy of Paediatrics, Brussels, Belgium.
Acta paediatrica (Oslo, Norway : 1992)
|December 4, 2025
概括
欧洲的初级儿科护理在整合和数字工具方面取得了进展,但对于青少年和数字基础设施仍然存在重大差距. 协调培训和投资数字系统对于公平,高质量的儿童医疗保健至关重要.
科学领域:
- 儿科初级医疗保健的儿童初级医疗保健.
- 欧洲的医疗保健系统
- 儿童和青少年健康问题
背景情况:
- 欧洲儿童和青少年的初级保健正在发展.
- 医疗保健系统在模型,劳动力和数字化整合方面面临着挑战.
- 需要对改善儿科护理质量的政策影响.
研究的目的:
- 提供欧洲各地初级儿科护理的最新概述.
- 调查不断发展的医疗保健系统,确定进展和差距.
- 为决策者提供有关加强欧洲儿科医疗保健的信息.
主要方法:
- 在欧洲儿科组织的全国代表中进行横截面调查.
- 从42个成员国收集了关于现实世界实施的数据.
- 关于提供初级儿科护理的标准化,国家级数据.
主要成果:
- 综合护理模式是最常见的 (45.2%),有28.6%的国家转向它们.
- 儿科医生的参与随着年龄的增长而减少;全科医生的参与增加.
- 在互操作的电子健康记录 (35.9%),预防性护理,青少年访问和培训方面存在重大差距.
结论:
- 护理整合和数字化采用的进展与青少年和数字基础设施的持续差异形成鲜明对比.
- 未来的模型需要协调培训,解决区域不平等问题,并投资于互操作的数字健康.
- 公平,高质量的儿科初级保健需要在这些领域进行战略性改进.
相关概念视频
Primary Healthcare Services
1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
231
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
231
Pharmacokinetics in Pediatric Patients: Drug Metabolism
176
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
176
Secondary Healthcare System
1.9K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.9K
Principles of Disease Surveillance
440
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
440
Pharmacokinetics in Pediatric Patients: Drug Distribution
244
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
244


